Literature DB >> 15528619

QT interval increased after single dose of lofexidine.

John Schmittner1, Jennifer R Schroeder, David H Epstein, Kenzie L Preston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15528619      PMCID： PMC526119          DOI： 10.1136/bmj.329.7474.1075

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  The QT interval.

Authors:  M M Bednar; E P Harrigan; R J Anziano; A J Camm; J N Ruskin
Journal:  Prog Cardiovasc Dis       Date:  2001 Mar-Apr       Impact factor: 8.194

Review 2.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

3.  Lofexidine and clonidine in moderate essential hypertension.

Authors:  L H Wilkins; S R Winternitz; S Oparil; L R Smith; H P Dustan
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

4.  Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine.

Authors:  T H Tsai; R E Beitman; J P Gibson; E J Larson; H Friehe; R Fontaine
Journal:  Arzneimittelforschung       Date:  1982
  4 in total
  4 in total

1.  Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal.

Authors:  Börje Darpö; Mark Pirner; James Longstreth; Georg Ferber
Journal:  Drug Alcohol Depend       Date:  2019-09-27       Impact factor: 4.492

Review 2.  Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Authors:  Jose Martinez-Raga; Carlos Knecht; Nestor Szerman; María I Martinez
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

3.  Clonidine blocks stress-induced craving in cocaine users.

Authors:  Michelle L Jobes; Udi E Ghitza; David H Epstein; Karran A Phillips; Stephen J Heishman; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2011-03-12       Impact factor: 4.530

4.  Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.

Authors:  John Schmittner; Jennifer R Schroeder; David H Epstein; Mori J Krantz; Nicole C Eid; Kenzie L Preston
Journal:  Pharmacotherapy       Date:  2009-05       Impact factor: 4.705
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.